logo

Italy Neurology Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The market is segmented By Type of Device (Cerebrospinal Fluid Management Device, Interventional Neurology Device, Neurosurgery Device, Neurostimulation Device and Other Type of Devices)

Home Industry Reports Healthcare Italy Neurology Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts ...

Market Snapshot

CAGR
Study Period: 2018 - 2026
Base Year: 2020
CAGR: 5.8 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The major factors augmenting the growth of the neurology devices market in Italy includes increasing incidences of neurological disorders, technological advancements and rise in the aging population. Major neurological disorders include brain aneurysms, brain tumors, epilepsy, memory disorders, multiple sclerosis, Parkinson’s disease, peripheral neuropathy, spinal cord tumor, and stroke. Among neurological disorders, Alzheimer’s disease and other dementias account for 2.84% of the total number of deaths in high-income countries. The rising number of patients with neurological disorders, lead to high demand for early diagnosis of neurological conditions. Additionally, the increasing awareness among patients is expected to augment the neurology devices market.

Scope of the report

As per the scope of the report, Neurological devices are medical devices that help to diagnose, prevent, and treat a variety of neurological disorders and conditions, such as Alzheimer's disease, Parkinson’s disease, major depression, and traumatic brain injury.

By Type of Device
Cerebrospinal Fluid Management Device
Interventional Neurology Device
Interventional/Surgical Simulators
Neurothrombectomy Devices
Carotid Artery Stents
Others
Neurostimulation Device
Spinal Cord Stimulation Device
Deep Brain Stimulation Device
Sacral Nerve Stimulation Device
Other Neurostimulation Devices
Other Type of Devices

Report scope can be customized per your requirements. Click here.

Key Market Trends

Cerebrospinal Fluid Management Segment is Expected to Show Better Growth in the Forecast Years

Based on type of device, the market is segmented into cerebrospinal fluid management device, interventional neurology device, neurostimulation device and other type of devices. Cerebral spinal fluid (CSF) shunt systems are used to treat hydrocephalus, which is a common medical procedure and a life-saving treatment for many patients. These shunt systems drain excess fluid from the brain to another part of the body, where the fluid is absorbed as part of the circulatory process. The CSF imbalance can lead to elevated intracranial pressure (ICP), which can lead to a variety of complications. CSF shunts can be used to alleviate these problems in patients who suffer from hydrocephalus. The need for diagnosis and treatment of neurological disorders have made significant progress in recent years, which is expected to drive the market growth in the forecast period.

Italy Neurology - 2.png

To understand key trends, Download Sample Report

Competitive Landscape

The global players in the Italy neurology devices market are Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Johnson and Johnson, Medtronic PLC, MicroPort Scientific, Nihon Kohden Corporation, Penumbra Inc., Smith & Nephew plc, and Stryker Corporation.

Italy Neurology Devices Market 2.png

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Incidences of Neurological Disorders

      2. 4.2.2 Technological Advancements in Neurology Devices

      3. 4.2.3 Rise in the Aging Population

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Devices

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Type of Device

      1. 5.1.1 Cerebrospinal Fluid Management Device

      2. 5.1.2 Interventional Neurology Device

        1. 5.1.2.1 Interventional/Surgical Simulators

        2. 5.1.2.2 Neurothrombectomy Devices

        3. 5.1.2.3 Carotid Artery Stents

        4. 5.1.2.4 Others

      3. 5.1.3 Neurostimulation Device

        1. 5.1.3.1 Spinal Cord Stimulation Device

        2. 5.1.3.2 Deep Brain Stimulation Device

        3. 5.1.3.3 Sacral Nerve Stimulation Device

        4. 5.1.3.4 Other Neurostimulation Devices

      4. 5.1.4 Other Type of Devices

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 B. Braun Melsungen AG

      3. 6.1.3 Boston Scientific Corporation

      4. 6.1.4 Johnson and Johnson

      5. 6.1.5 Medtronic PLC

      6. 6.1.6 MicroPort Scientific

      7. 6.1.7 Nihon Kohden Corporation

      8. 6.1.8 Penumbra Inc.

      9. 6.1.9 Smith & Nephew plc

      10. 6.1.10 Stryker Corporation

      2. *List Not Exhaustive

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Italy Neurology Devices Market market is studied from 2018 - 2026.

The Italy Neurology Devices Market is growing at a CAGR of 5.8% over the next 5 years.

Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Medtronic PLC, Stryker Corporation are the major companies operating in Italy Neurology Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!